Skip to main content

Advertisement

Table 4 Health-care outcomes

From: Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

  2009 ( n= 2,098) 2010 ( n= 2,790) P value
Total N Mean or n SD or percentage Total N Mean or n SD or percentage
Any PACU time (n,%) 1,977 1,498 75.8 2,774 2,053 74 0.1681
PACU time (hrs, incl. 0) (mean, SD) 1,977 3.2 3.3 2,774 3.2 3.3 0.0848
PACU hrs if > 0 (mean, SD) 1,498 4.3 3.2 2,053 4.3 3.2 0.2991
Any ICU stay (n,%) 1,971 339 17.2 2,774 629 22.7 <0.0001
ICU days 1,971    2,774    <0.0001
None (n,%)   1,632 83   2,145 77 <0.0001
1 day (n,%)   137 7   247 9 0.0150
2 to 3 days (n,%)   114 6   189 7 0.1530
4+ days (n,%)   88 4   193 7 0.0003
Total ICU days (incl. 0) (mean, SD) 1,971 0.9 4.8 2,774 1 4.2 <0.0001
ICU days if > 0 (mean, SD) 339 5.2 10.7 629 4.5 7.8 0.3676
Highest postop creatinine (mean, SD) 1,901 1.2 1 2,634 1.4 1.5 0.0884
Creatinine pre-post percentage change (mean, SD) 1,310 24.1 69 1,735 24.1 63.6 0.4533
LOS (days) (mean, SD) 1,977 7.3 9.2 2,774 7.3 9.6 0.8711
Death - 30 days (n,%) 1,977 32 1.6 2,774 49 1.8 0.6981
Death - 1 year (n,%) 1,977 164 8.3 2,774 238 8.6 0.7286
  1. PACU, post-anesthesia care units; postop, postoperative; hrs, hours; SD, standard deviation; ICU, intensive care unit; creatinine pre-post, creatinine pre-surgery post-surgery; LOS, length of stay.